RecruitingNot ApplicableNCT06472089

BMT-CARE: Psychosocial Intervention for Transplant Caregivers

Multimodal Psychosocial Intervention for Caregivers of Patients Undergoing Hematopoietic Stem Cell Transplantation


Sponsor

Massachusetts General Hospital

Enrollment

800 participants

Start Date

Jan 10, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this study is to evaluate whether a psychological intervention (BMT-CARE) is effective at improving the quality of life in caregivers and patients treated with hematopoietic cell transplant compared to usual care, and to identify critical facilitators and barriers for BMT-CARE implementation and adoption.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called BMT-CARE and a behavioral approach called Usual Care for people with bone marrow transplant complications and hematologic malignancy. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALBMT-CARE

Therapist-delivered psychosocial intervention comprised of 6 sessions

BEHAVIORALUsual Care

Meeting a transplant social worker prior to HCT and as needed for extra visits


Locations(3)

University of Alabama at Brimingham

Birmingham, Alabama, United States

Moffitt Cancer Center

Tampa, Florida, United States

Massachusetts General Hospital Cancer Center

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06472089


Related Trials